The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Left Ventricular Assist Device Treatment-Global Market Insights and Sales Trends 2024

Left Ventricular Assist Device Treatment-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1856396

No of Pages : 102

Synopsis
Left Ventricular Assist Device is used to treat heart failure, as the bridge to transplant or destination therapy.
The global Left Ventricular Assist Device Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Left Ventricular Assist Device Treatment in various end use industries. The expanding demands from the Hospitals and Cardiology Centers, are propelling Left Ventricular Assist Device Treatment market. Destination Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bridge to Transplantation segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Left Ventricular Assist Device Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Left Ventricular Assist Device Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Left Ventricular Assist Device Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Left Ventricular Assist Device Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Left Ventricular Assist Device Treatment covered in this report include Abbott, Abiomed, Berlin Heart, Thoratec, Jarvik Heart, HeartWare, Apaxis, CorWave and Evaheart, etc.
The global Left Ventricular Assist Device Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Abiomed
Berlin Heart
Thoratec
Jarvik Heart
HeartWare
Apaxis
CorWave
Evaheart
Reliantheart
Global Left Ventricular Assist Device Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Left Ventricular Assist Device Treatment market, Segment by Type:
Destination Therapy
Bridge to Transplantation
Bridge to Recovery
Bridge to Destination
Global Left Ventricular Assist Device Treatment market, by Application
Hospitals
Cardiology Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Left Ventricular Assist Device Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Left Ventricular Assist Device Treatment
1.1 Left Ventricular Assist Device Treatment Market Overview
1.1.1 Left Ventricular Assist Device Treatment Product Scope
1.1.2 Left Ventricular Assist Device Treatment Market Status and Outlook
1.2 Global Left Ventricular Assist Device Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Left Ventricular Assist Device Treatment Market Size by Region (2018-2029)
1.4 Global Left Ventricular Assist Device Treatment Historic Market Size by Region (2018-2023)
1.5 Global Left Ventricular Assist Device Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Left Ventricular Assist Device Treatment Market Size (2018-2029)
1.6.1 North America Left Ventricular Assist Device Treatment Market Size (2018-2029)
1.6.2 Europe Left Ventricular Assist Device Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Left Ventricular Assist Device Treatment Market Size (2018-2029)
1.6.4 Latin America Left Ventricular Assist Device Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Left Ventricular Assist Device Treatment Market Size (2018-2029)
2 Left Ventricular Assist Device Treatment Market by Type
2.1 Introduction
2.1.1 Destination Therapy
2.1.2 Bridge to Transplantation
2.1.3 Bridge to Recovery
2.1.4 Bridge to Destination
2.2 Global Left Ventricular Assist Device Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Left Ventricular Assist Device Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Left Ventricular Assist Device Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Left Ventricular Assist Device Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Left Ventricular Assist Device Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Left Ventricular Assist Device Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Left Ventricular Assist Device Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Left Ventricular Assist Device Treatment Revenue Breakdown by Type (2018-2029)
3 Left Ventricular Assist Device Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Cardiology Centers
3.2 Global Left Ventricular Assist Device Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Left Ventricular Assist Device Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Left Ventricular Assist Device Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Left Ventricular Assist Device Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Left Ventricular Assist Device Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Left Ventricular Assist Device Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Left Ventricular Assist Device Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Left Ventricular Assist Device Treatment Revenue Breakdown by Application (2018-2029)
4 Left Ventricular Assist Device Treatment Competition Analysis by Players
4.1 Global Left Ventricular Assist Device Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Left Ventricular Assist Device Treatment as of 2022)
4.3 Date of Key Players Enter into Left Ventricular Assist Device Treatment Market
4.4 Global Top Players Left Ventricular Assist Device Treatment Headquarters and Area Served
4.5 Key Players Left Ventricular Assist Device Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Left Ventricular Assist Device Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Left Ventricular Assist Device Treatment Products, Services and Solutions
5.1.4 Abbott Left Ventricular Assist Device Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Abiomed
5.2.1 Abiomed Profile
5.2.2 Abiomed Main Business
5.2.3 Abiomed Left Ventricular Assist Device Treatment Products, Services and Solutions
5.2.4 Abiomed Left Ventricular Assist Device Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Abiomed Recent Developments
5.3 Berlin Heart
5.3.1 Berlin Heart Profile
5.3.2 Berlin Heart Main Business
5.3.3 Berlin Heart Left Ventricular Assist Device Treatment Products, Services and Solutions
5.3.4 Berlin Heart Left Ventricular Assist Device Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Thoratec Recent Developments
5.4 Thoratec
5.4.1 Thoratec Profile
5.4.2 Thoratec Main Business
5.4.3 Thoratec Left Ventricular Assist Device Treatment Products, Services and Solutions
5.4.4 Thoratec Left Ventricular Assist Device Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Thoratec Recent Developments
5.5 Jarvik Heart
5.5.1 Jarvik Heart Profile
5.5.2 Jarvik Heart Main Business
5.5.3 Jarvik Heart Left Ventricular Assist Device Treatment Products, Services and Solutions
5.5.4 Jarvik Heart Left Ventricular Assist Device Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Jarvik Heart Recent Developments
5.6 HeartWare
5.6.1 HeartWare Profile
5.6.2 HeartWare Main Business
5.6.3 HeartWare Left Ventricular Assist Device Treatment Products, Services and Solutions
5.6.4 HeartWare Left Ventricular Assist Device Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 HeartWare Recent Developments
5.7 Apaxis
5.7.1 Apaxis Profile
5.7.2 Apaxis Main Business
5.7.3 Apaxis Left Ventricular Assist Device Treatment Products, Services and Solutions
5.7.4 Apaxis Left Ventricular Assist Device Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Apaxis Recent Developments
5.8 CorWave
5.8.1 CorWave Profile
5.8.2 CorWave Main Business
5.8.3 CorWave Left Ventricular Assist Device Treatment Products, Services and Solutions
5.8.4 CorWave Left Ventricular Assist Device Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 CorWave Recent Developments
5.9 Evaheart
5.9.1 Evaheart Profile
5.9.2 Evaheart Main Business
5.9.3 Evaheart Left Ventricular Assist Device Treatment Products, Services and Solutions
5.9.4 Evaheart Left Ventricular Assist Device Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Evaheart Recent Developments
5.10 Reliantheart
5.10.1 Reliantheart Profile
5.10.2 Reliantheart Main Business
5.10.3 Reliantheart Left Ventricular Assist Device Treatment Products, Services and Solutions
5.10.4 Reliantheart Left Ventricular Assist Device Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Reliantheart Recent Developments
6 North America
6.1 North America Left Ventricular Assist Device Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Left Ventricular Assist Device Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Left Ventricular Assist Device Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Left Ventricular Assist Device Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Left Ventricular Assist Device Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Left Ventricular Assist Device Treatment Market Dynamics
11.1 Left Ventricular Assist Device Treatment Industry Trends
11.2 Left Ventricular Assist Device Treatment Market Drivers
11.3 Left Ventricular Assist Device Treatment Market Challenges
11.4 Left Ventricular Assist Device Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’